Clinical Trials Directory

Trials / Terminated

TerminatedNCT01533818

Community Based Management of Fast Breathing in Infants Aged < 60 Days in Low-income Settlements of Karachi

Community Based Management of Fast Breathing in Infants Aged < 60 Days: A Double-Blind, Randomized Placebo-Controlled Trial in Low-income Settlements of Karachi

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
963 (actual)
Sponsor
Aga Khan University · Academic / Other
Sex
All
Age
59 Days
Healthy volunteers
Not accepted

Summary

The aim of the study is to determine optimal management of isolated fast breathing in young infants in a trial design conducted in primary care settings. The investigators hypothesized that proportion of infants who fail therapy will be 4% in each group. A 6% or less difference in failure rate will be considered equivalent.

Detailed description

The management of isolated fast breathing is therefore unknown and our experience suggests that these infants could perhaps be managed without antibiotics. Widespread application of the WHO clinical algorithm could therefore result in the referral of as many as 13.7% (135.7 per 1000 live births) of all infants for isolated fast breathing, the vast majority of these unnecessarily, and exposing infants to a high risk of nosocomial sepsis and hospital mortality in addition to over-burdening health resources.

Conditions

Interventions

TypeNameDescription
DRUGAmoxicillin80-100 mg/kg/day in 2 divided doses for 7 days For convenience dose divided into six weight bands Table 2: Dose of amoxicillin Weight band Amount per dose Daily dose Lower Limit (mg or units /kg/d) Upper Limit (mg or units /kg/d) Amoxicillin - desired range 75-100 mg/kg/day (25mg/ml (125mg/5ml); twice daily orally)\* 1.8-1.9 kg 3.0 ml 150 mg 75.4 100.0 2.0-2.4 kg 4.0 ml 200 mg 80.3 100.0 2.5-2.9 kg 5.0 ml 250 mg 83.6 100.0 3.0-3.9 kg 6.0 ml 300 mg 75.2 100.0 4.0-4.9 kg 8.0 ml 400 mg 80.2 100.0 5.0-5.9 kg 10.0 ml 500 mg 83.5 100.0
DRUGSugar SyrupIt will be given 2 times/day for 7 days

Timeline

Start date
2012-05-01
Primary completion
2014-05-01
Completion
2014-05-01
First posted
2012-02-15
Last updated
2014-06-03

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT01533818. Inclusion in this directory is not an endorsement.